Schavgoulidze, A., Perrot, A., Leleu, X., Cazaubiel, T., Chretien, M., Feugier, P., Belhadj, K., Manier, S., Roussel, M., Brechignac, S., Orsini-Piocelle, F., Mohty, M., Collela, J. S. D., Macro, M., Adiko, D., Dib, M., Fontan, J., Luttiau-Motard, C., Bouscary, D., Pascal, L., Roland, V., Lifermann, F., Bakala, J., Montes, L., Kennel, C., Rey, P., Richez, V., Keddar, F., Frenzel, L., Calmettes, C., Chaleteix, C., Plantier, I., Chalayer, E., Schmitt, A., Roul, C., Demarquette, H., Cerutti, C., Pavageau, L., Derrier, L., Avet-Loiseau, H., Corre, J. (2026). High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing. Blood. https://doi.org/10.1182/blood.2025029999